NZ594184A - Skin treatment - Google Patents
Skin treatmentInfo
- Publication number
- NZ594184A NZ594184A NZ594184A NZ59418410A NZ594184A NZ 594184 A NZ594184 A NZ 594184A NZ 594184 A NZ594184 A NZ 594184A NZ 59418410 A NZ59418410 A NZ 59418410A NZ 594184 A NZ594184 A NZ 594184A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ingenol
- skin
- aged
- angelate
- subject
- Prior art date
Links
- VEBVPUXQAPLADL-UHFFFAOYSA-N Ingenol Natural products C1=C(CO)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O VEBVPUXQAPLADL-UHFFFAOYSA-N 0.000 abstract 3
- -1 ingenol compound Chemical class 0.000 abstract 3
- 206010064127 Solar lentigo Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000037303 wrinkles Effects 0.000 abstract 2
- UQOWJJGOQJONCI-UHFFFAOYSA-N 20-deoxyingenol-3-angelate Natural products CC1CC2C(C)(C)C2C2C=C(C)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O UQOWJJGOQJONCI-UHFFFAOYSA-N 0.000 abstract 1
- UQOWJJGOQJONCI-MZRDIQIISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O UQOWJJGOQJONCI-MZRDIQIISA-N 0.000 abstract 1
- ZYCAGKYWXRKLSN-KLKWOBOISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O ZYCAGKYWXRKLSN-KLKWOBOISA-N 0.000 abstract 1
- VDJHFHXMUKFKET-UHFFFAOYSA-N Ingenol mebutate Natural products CC1CC2C(C)(C)C2C2C=C(CO)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O VDJHFHXMUKFKET-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 1
- 229940099552 hyaluronan Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- VDJHFHXMUKFKET-WDUFCVPESA-N ingenol mebutate Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(CO)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O VDJHFHXMUKFKET-WDUFCVPESA-N 0.000 abstract 1
- 229960002993 ingenol mebutate Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15259909P | 2009-02-13 | 2009-02-13 | |
| PCT/AU2010/000152 WO2010091472A1 (en) | 2009-02-13 | 2010-02-12 | Skin treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ594184A true NZ594184A (en) | 2014-01-31 |
Family
ID=42561329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ594184A NZ594184A (en) | 2009-02-13 | 2010-02-12 | Skin treatment |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10143638B2 (https=) |
| EP (1) | EP2395993B1 (https=) |
| JP (1) | JP5638008B2 (https=) |
| CN (1) | CN102316866A (https=) |
| AU (1) | AU2010213362B2 (https=) |
| CA (1) | CA2752389C (https=) |
| DK (1) | DK2395993T3 (https=) |
| ES (1) | ES2633755T3 (https=) |
| IL (1) | IL214133A (https=) |
| NZ (1) | NZ594184A (https=) |
| PL (1) | PL2395993T3 (https=) |
| PT (1) | PT2395993T (https=) |
| RU (1) | RU2491050C2 (https=) |
| WO (1) | WO2010091472A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9402823B2 (en) | 2010-12-17 | 2016-08-02 | Leo Laboratories Limited | Ingenols for treating seborrheic keratosis |
| CN103402969A (zh) * | 2010-12-22 | 2013-11-20 | 利奥实验室有限公司 | 3-酰基-巨大戟二萜醇ii |
| JP2014507396A (ja) * | 2010-12-22 | 2014-03-27 | レオ・ラボラトリーズ・リミテッド | イノゲノール−３−アシラートｉ |
| WO2012176015A1 (en) | 2011-06-24 | 2012-12-27 | Leo Pharma A/S | Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate |
| US20140350101A1 (en) * | 2011-12-12 | 2014-11-27 | Leo Laboratories Limited | Gel compositions |
| EP2790670A1 (en) * | 2011-12-12 | 2014-10-22 | Leo Laboratories Limited | Gel compositions |
| US20150366789A1 (en) * | 2013-03-13 | 2015-12-24 | Avon Place, Inc. | Glochidium wallichianum extracts and methods of use |
| US9526714B2 (en) | 2014-03-24 | 2016-12-27 | Leo Laboratories Limited | Method for treating skin lesions with ingenol mebutate |
| AU2014100280B4 (en) * | 2014-03-24 | 2015-01-15 | Leo Pharma A/S | A method of treating skin lesions |
| BR112018074202B1 (pt) * | 2016-05-24 | 2022-08-02 | Natura Cosméticos S.A | Composição cosmética antissinais, kit de composições e método para tratamento cosmético da pele |
| JP7557192B2 (ja) | 2020-08-19 | 2024-09-27 | 日本メナード化粧品株式会社 | 皮膚外用剤及び内用剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08176004A (ja) * | 1994-12-21 | 1996-07-09 | Lion Corp | 生体老化防止剤及び皮膚用組成物 |
| JPH0987136A (ja) * | 1995-07-13 | 1997-03-31 | Shiseido Co Ltd | 皮膚外用剤 |
| AUPO864097A0 (en) | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
| AU750624B2 (en) * | 1997-08-19 | 2002-07-25 | Leo Laboratories Limited | Anti-cancer compounds-I |
| KR20010057776A (ko) * | 1999-12-23 | 2001-07-05 | 성재갑 | 피부미백제 |
| JP4880816B2 (ja) | 2000-12-15 | 2012-02-22 | 株式会社ヤクルト本社 | 皮膚老化防止剤 |
| JP3935360B2 (ja) * | 2002-01-22 | 2007-06-20 | 丸善製薬株式会社 | ヒアルロン酸産生促進剤並びに皮膚化粧料及び美容用飲食品 |
| RU2229293C1 (ru) * | 2003-04-24 | 2004-05-27 | Хазанов Вениамин Абрамович | Лечебно-профилактическое средство для использования в геронтологической практике |
| US20070224150A1 (en) * | 2005-03-24 | 2007-09-27 | Yongji Chung | Growth factor for hair and skin treatment |
| JP2007084448A (ja) * | 2005-09-20 | 2007-04-05 | Shiseido Co Ltd | ヒアルロン酸産生促進剤および皮膚外用剤 |
| BRPI0504797B1 (pt) | 2005-10-27 | 2020-02-04 | Pele Nova Biotecnologia S.A. | formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação |
| KR20080077625A (ko) * | 2005-11-25 | 2008-08-25 | 페플린 리서치 피티이 리미티드 | 상처 치유 방법 |
| SI2152261T1 (sl) | 2007-04-30 | 2016-05-31 | Leo Laboratories Limited | Zdravljenje viralno induciranih lezij |
| EP2558435B1 (en) * | 2010-04-16 | 2017-06-07 | Leo Pharma A/S | Orthorhombic crystalline ingenol mebutate |
-
2010
- 2010-02-12 JP JP2011549394A patent/JP5638008B2/ja not_active Expired - Fee Related
- 2010-02-12 CA CA2752389A patent/CA2752389C/en not_active Expired - Fee Related
- 2010-02-12 PT PT107408478T patent/PT2395993T/pt unknown
- 2010-02-12 US US13/201,331 patent/US10143638B2/en not_active Expired - Fee Related
- 2010-02-12 WO PCT/AU2010/000152 patent/WO2010091472A1/en not_active Ceased
- 2010-02-12 PL PL10740847T patent/PL2395993T3/pl unknown
- 2010-02-12 RU RU2011137530/15A patent/RU2491050C2/ru not_active IP Right Cessation
- 2010-02-12 EP EP10740847.8A patent/EP2395993B1/en not_active Not-in-force
- 2010-02-12 NZ NZ594184A patent/NZ594184A/en not_active IP Right Cessation
- 2010-02-12 ES ES10740847.8T patent/ES2633755T3/es active Active
- 2010-02-12 CN CN2010800074880A patent/CN102316866A/zh active Pending
- 2010-02-12 AU AU2010213362A patent/AU2010213362B2/en not_active Ceased
- 2010-02-12 DK DK10740847.8T patent/DK2395993T3/en active
-
2011
- 2011-07-18 IL IL214133A patent/IL214133A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012517450A (ja) | 2012-08-02 |
| RU2011137530A (ru) | 2013-03-20 |
| JP5638008B2 (ja) | 2014-12-10 |
| EP2395993B1 (en) | 2017-06-21 |
| AU2010213362A1 (en) | 2011-08-04 |
| PT2395993T (pt) | 2017-07-18 |
| CN102316866A (zh) | 2012-01-11 |
| PL2395993T3 (pl) | 2017-10-31 |
| CA2752389C (en) | 2017-01-03 |
| US10143638B2 (en) | 2018-12-04 |
| CA2752389A1 (en) | 2010-08-19 |
| US20120041064A1 (en) | 2012-02-16 |
| WO2010091472A1 (en) | 2010-08-19 |
| EP2395993A4 (en) | 2014-09-03 |
| IL214133A0 (en) | 2011-08-31 |
| ES2633755T3 (es) | 2017-09-25 |
| DK2395993T3 (en) | 2017-08-07 |
| IL214133A (en) | 2015-03-31 |
| RU2491050C2 (ru) | 2013-08-27 |
| EP2395993A1 (en) | 2011-12-21 |
| AU2010213362B2 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ594184A (en) | Skin treatment | |
| EP4442241A3 (en) | Retinol replacement in skin treatment | |
| MX337830B (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. | |
| MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| MX2010013766A (es) | Rasagilina para modificacion de enfermedad de parkinson. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| WO2012082718A3 (en) | 3-methanesulfonylpropionitrile for treating inflammation and pain | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| WO2012050831A3 (en) | Combination treatment for dermatological conditions | |
| UA101393C2 (ru) | КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ | |
| NZ612717A (en) | Treatment of pain associated with dislocation of basal endometrium | |
| PT2459153E (pt) | Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar | |
| EA201171087A1 (ru) | СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ | |
| SA519410993B1 (ar) | النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية | |
| TW200719882A (en) | Treatment of connective tissue diseases of the skin | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| MX342798B (es) | Compuesto de ácido (2s)-2-amino-3-(3,4-bis((2-(benzoiloxi)-2-metil propanoil)oxi)-fenil)propanóico y uso médico del mismo. | |
| WO2010107251A2 (ko) | 파카스트리사민을 유효성분으로 함유하는 과증식성 피부질환과 악성흑생종의 예방 또는 치료용 약학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: LEO LABORATORIES LIMITED, IE Free format text: OLD OWNER(S): PEPLIN RESEARCH PTY LTD |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 FEB 2017 BY DAVIES COLLISON CAVE Effective date: 20140502 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 FEB 2018 BY COMPUTER PACKAGES INC Effective date: 20170118 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 FEB 2019 BY COMPUTER PACKAGES INC Effective date: 20180118 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 FEB 2020 BY COMPUTER PACKAGES INC Effective date: 20190118 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 FEB 2021 BY COMPUTER PACKAGES INC Effective date: 20200118 |
|
| LAPS | Patent lapsed |